LONDON, ONTARIO--(MARKET WIRE)--Mar 31, 2008 -- Stellar Pharmaceuticals Inc. (CDNX:SLX.V - News)(OTC BB:SLXCF.OB - News) (“Stellar” or “the Company”), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced financial results for the three and twelve months ended December 31, 2007. This is the second consecutive quarter that the Company has recorded a profit from its operations. Amounts shown in this press release are in Canadian dollars, rounded to the nearest one hundred dollars and are the result of the use of U.S. generally accepted accounting principles.
